Sorted By:

Relevance


Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

For more information about how America’s biopharmaceutical companies are fighting cardiovascular disease, visit http://www.fromhopetocures.org/fighting-cardiovascular-diseases.
http://catalyst.phrma.org/celebrating-hope-for-patients-and-families-on-world-heart-day-2016

Medicines in Development for Heart Disease & Stroke 2015

PhRMA  |  Report

Heart disease has been the leading cause of death in the United States since 1921, but these numbers are declining.
https://www.phrma.org/report/medicines-in-development-for-heart-disease-and-stroke-2015-report

Working for Patients

From Hope To Cures  |  From PhRMA

2  And while hepatitis C was incurable in half of patients just a decade ago, new treatments have cure rates upwards of 90 percent and have far fewer side effects.
http://www.fromhopetocures.org/working-for-patients/working-for-patients

Supporting opportunities for enhanced competition in the marketplace

PhRMA  |  Blog Post

Fostering robust innovation will continue to enhance the competitive marketplace for biopharmaceuticals.
http://catalyst.phrma.org/supporting-opportunities-for-enhanced-competition-in-the-marketplace

Patient Profile: Out-of-Pocket Cost Burden for Patients Treating HIV/AIDS

PhRMA  |  Blog Post

Visit the Access Better Coverage website for more on understanding health insurance and getting the information you need to choose the plan that is best for you and your family.
http://catalyst.phrma.org/patient-profile-out-of-pocket-cost-burden-for-patients-treating-hiv/aids

Leading Biopharmaceutical Researchers to Showcase the New Era of Medicine on Capitol Hill

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit:  www.PhRMA.org www.Innovation.org www.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/leading-biopharmaceutical-researchers-to-showcase-the-new-era-of-medicine-on-capitol-hill

I'm Not Average: Matt May Have Cancer, but Cancer Doesn’t Have Him

PhRMA  |  Blog Post

For more information on the I’m Not Average campaign, please visit www.phrma.org/cancer.
http://catalyst.phrma.org/im-not-average-matt-may-have-cancer-but-cancer-doesnt-have-him

Common Conditions for Older Americans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/common-conditions-for-older-americans

340B Then & Now

PhRMA  |  Graphic

A closer look at how the 340B program has evolved since its creation in 1992.
https://www.phrma.org/graphic/340b-then-and-now

Medicare Monday: How Part D Helps Parkinson’s Patients

PhRMA  |  Graphic

Specifically, compared to patients with low adherence, those with high adherence had significantly lower rates of hospitalization, emergency room visits, skilled nursing facility episodes, home health agency episodes, physician visits and lower total health expenditures of more than $2,000, measured over 19 months.
https://www.phrma.org/graphic/medicare-monday-how-part-d-helps-parkinson-s-patients

Foreign government pricing setting by any name harms innovation and access to medicines

PhRMA  |  Blog Post

These financial penalties have nothing to do with a product’s value, and serve to disadvantage U.S. manufacturers.
http://catalyst.phrma.org/foreign-gov-pricing-setting-by-any-name-harms-innovation-and-access-to-medicines

How Medicine Purchased at a Canadian Internet Pharmacy Could Actually Be Fake

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/how-medicine-purchased-at-a-canadian-internet-pharmacy-could-actually-be-fake

First Transplant from HIV-Positive Donor Performed in U.S.

From Hope To Cures  |  From Our Network

“We are very thankful to Congress, the President and the entire transplant community for letting us use organs from HIV-positive patients to save lives instead of throwing them away, as we had to do for so many years,” said Dr.
http://www.fromhopetocures.org/first-transplant-from-hiv-positive-donor-performed-in-u-s

Medicare Monday: Have you heard of CMMI?

PhRMA  |  Blog Post

CMMI is required to seek input from interested parties as it develops and tests models, but has been inconsistent in when and how it engages stakeholders.
http://catalyst.phrma.org/medicare-monday-have-you-heard-of-cmmi

Medicines in Development for Older Americans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicines-in-development-for-older-americans

Guest Post: Room for optimism in ALS research

PhRMA  |  Blog Post

I have worked closely with biotech/pharma leaders as well as nonprofits in both those fields for more than a decade and seeing their excitement following the approval of treatments for those disease gives me so much inspiration and hope that we will see it in ALS and all rare diseases!
http://catalyst.phrma.org/guest-post-room-for-optimism-in-als-research

Print Ad: Hospital Markups

PhRMA  |  Graphic

These hospital markups lead to higher costs for everyone - patients, employers and payers.
https://www.phrma.org/graphic/print-ad-hospital-markups

Paying for Outcomes in Medicine:

PhRMA  |  Graphic

For patients, these arrangements can offer important benefits -- medicines that work best for them and, often, reduced patient costs.
https://www.phrma.org

High Cholesterol: Mapping Unmet Need

PhRMA  |  Graphic

PCSK9 inhibitors will help those who cannot be treated with existing cholesterol-lowering medicines and are just one of many opportunities for those with uncontrolled cholesterol.
https://www.phrma.org/graphic/high-cholesterol-mapping-unmet-need

Medicare Monday: How Medicare helps beneficiaries access needed medicines

PhRMA  |  Blog Post

Susan has been living with schizophrenia.
http://catalyst.phrma.org/how-medicare-helps-beneficiaries-access-needed-medicines

Rare Disease Day: Accelerating innovation for patients in need

PhRMA  |  Blog Post

There are more than 560 medicines currently in development for rare diseases, including more than 150 for rare forms of cancer.
http://catalyst.phrma.org/rare-disease-day-accelerating-innovation-for-patients-in-need

How We’re Curing The Incurable

PhRMA  |  Blog Post

New therapies are projected to provide even greater cure rates, more options for patients with different hepatitis C strains, shorter duration of treatment, and – eventually – we can tear down the wall between hepatitis C and its absolute cure.
http://catalyst.phrma.org/how-were-curing-the-incurable

Medicines in Development for Mental Illnesses 2017 Report

PhRMA  |  Report

For example, medicines for treating depression are helping millions of people live productive lives and advances in schizophrenia medicines have enabled patients to avoid hospitalization and receive treatment in an outpatient setting. 
https://www.phrma.org/report/medicines-in-development-for-mental-illnesses-2017-report

ICYMI Report highlights increasing prevalence for Alzheimer's disease

PhRMA  |  Blog Post

Biopharmaceutical researchers however remain committed to finding treatments for Alzheimer’s and are currently researching 85 potential medicines.
http://catalyst.phrma.org/icymi-report-highlights-increasing-prevalence-for-alzheimers-disease

Where'd My Discount Go?

PhRMA  |  Graphic

Learn more at PhRMA.org/discounts....
https://www.phrma.org/where-did-my-discount-go

You have reviewed the first 125 results out of 2564. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next